Renhe Pharmacy Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.027x

Renhe Pharmacy Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Renhe Pharmacy Co Ltd (000650) has a cash flow conversion efficiency ratio of 0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥188.23 Million ≈ $27.54 Million USD) by net assets (CN¥7.04 Billion ≈ $1.03 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Renhe Pharmacy Co Ltd (1998–2025)

Cash flow conversion efficiency of Renhe Pharmacy Co Ltd from 1998 to 2025. This chart illustrates how Renhe Pharmacy Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Renhe Pharmacy Co Ltd share price for real-time trading data and today's change.

Renhe Pharmacy Co Ltd Cash Flow Conversion Ratio Explained

Renhe Pharmacy Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Renhe Pharmacy Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Renhe Pharmacy Co Ltd ranked by their cash flow conversion efficiency. Also see Renhe Pharmacy Co Ltd stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Fujian Aonong Biological Technology Group Incorporation Ltd
SHG:603363
0.009x
Jiuzhitang Co Ltd
SHE:000989
0.027x
Shanghai Taisheng Wind Power
SHE:300129
0.049x
Storytel AB (publ)
ST:STORY-B
0.099x
Anhui Water Resources Development Co Ltd
SHG:600502
0.018x
Shenzhen Clou Electronics Co Ltd
SHE:002121
0.146x
Corbion N.V.
F:CSU
0.038x
China Resources Boya Bio pharmaceutical Group Co Ltd
SHE:300294
0.005x

Annual Cash Flow Conversion Efficiency for Renhe Pharmacy Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Renhe Pharmacy Co Ltd from 1998 to 2025. Review 000650 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥6.93 Billion
≈ $1.01 Billion
CN¥851.31 Million
≈ $124.57 Million
0.123x +49.99%
2024-12-31 CN¥6.81 Billion
≈ $995.93 Million
CN¥557.26 Million
≈ $81.54 Million
0.082x +9.09%
2023-12-31 CN¥6.65 Billion
≈ $973.76 Million
CN¥499.47 Million
≈ $73.09 Million
0.075x -62.05%
2022-12-31 CN¥6.42 Billion
≈ $939.71 Million
CN¥1.27 Billion
≈ $185.84 Million
0.198x +50.71%
2021-12-31 CN¥5.93 Billion
≈ $867.29 Million
CN¥777.72 Million
≈ $113.80 Million
0.131x -15.49%
2020-12-31 CN¥5.61 Billion
≈ $820.99 Million
CN¥871.13 Million
≈ $127.47 Million
0.155x -2.63%
2019-12-31 CN¥4.35 Billion
≈ $636.83 Million
CN¥693.97 Million
≈ $101.55 Million
0.159x +9.63%
2018-12-31 CN¥3.91 Billion
≈ $572.89 Million
CN¥569.45 Million
≈ $83.33 Million
0.145x +1.45%
2017-12-31 CN¥3.47 Billion
≈ $508.13 Million
CN¥497.86 Million
≈ $72.85 Million
0.143x -12.00%
2016-12-31 CN¥3.20 Billion
≈ $468.92 Million
CN¥522.08 Million
≈ $76.40 Million
0.163x -2.54%
2015-12-31 CN¥2.60 Billion
≈ $380.59 Million
CN¥434.77 Million
≈ $63.62 Million
0.167x -1.06%
2014-12-31 CN¥2.16 Billion
≈ $316.38 Million
CN¥365.27 Million
≈ $53.45 Million
0.169x +53.53%
2013-12-31 CN¥1.94 Billion
≈ $283.72 Million
CN¥213.36 Million
≈ $31.22 Million
0.110x +2.41%
2012-12-31 CN¥1.71 Billion
≈ $250.53 Million
CN¥183.97 Million
≈ $26.92 Million
0.107x -26.48%
2011-12-31 CN¥1.14 Billion
≈ $167.13 Million
CN¥166.93 Million
≈ $24.43 Million
0.146x +2.48%
2010-12-31 CN¥912.05 Million
≈ $133.46 Million
CN¥130.07 Million
≈ $19.03 Million
0.143x -39.05%
2009-12-31 CN¥857.16 Million
≈ $125.43 Million
CN¥200.58 Million
≈ $29.35 Million
0.234x +15.08%
2008-12-31 CN¥305.60 Million
≈ $44.72 Million
CN¥62.14 Million
≈ $9.09 Million
0.203x +35.25%
2007-12-31 CN¥235.44 Million
≈ $34.45 Million
CN¥35.40 Million
≈ $5.18 Million
0.150x -87.56%
2006-12-31 CN¥194.71 Million
≈ $28.49 Million
CN¥235.28 Million
≈ $34.43 Million
1.208x +421.39%
2005-12-31 CN¥46.88 Million
≈ $6.86 Million
CN¥-17.63 Million
≈ $-2.58 Million
-0.376x -462.08%
2004-12-31 CN¥169.04 Million
≈ $24.74 Million
CN¥17.55 Million
≈ $2.57 Million
0.104x +149.33%
2003-12-31 CN¥238.17 Million
≈ $34.85 Million
CN¥-50.14 Million
≈ $-7.34 Million
-0.211x -354.75%
2002-12-31 CN¥338.74 Million
≈ $49.57 Million
CN¥27.99 Million
≈ $4.10 Million
0.083x +702.09%
2001-12-31 CN¥331.58 Million
≈ $48.52 Million
CN¥3.42 Million
≈ $499.90K
0.010x +109.60%
2000-12-31 CN¥345.32 Million
≈ $50.53 Million
CN¥-37.08 Million
≈ $-5.43 Million
-0.107x -141.68%
1999-12-31 CN¥261.49 Million
≈ $38.26 Million
CN¥67.37 Million
≈ $9.86 Million
0.258x +316.08%
1998-12-31 CN¥233.76 Million
≈ $34.21 Million
CN¥14.48 Million
≈ $2.12 Million
0.062x --

About Renhe Pharmacy Co Ltd

SHE:000650 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.06 Billion
CN¥7.21 Billion CNY
Market Cap Rank
#8396 Global
#1912 in China
Share Price
CN¥5.15
Change (1 day)
+0.39%
52-Week Range
CN¥4.98 - CN¥6.38
All Time High
CN¥11.50
About

Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in … Read more